Literature DB >> 8774184

Eosinophils are an insignificant cellular component of rheumatoid synovium in patients with late stage disease: comparative distributions with mast cells and macrophages.

L C Tetlow1, D E Woolley.   

Abstract

OBJECTIVES: To examine the distribution of eosinophils in rheumatoid synovial tissue and to determine whether or not their tissue distribution is related to that of mast cells or macrophages.
METHODS: Consecutive tissue sections from 31 specimens of rheumatoid synovial tissue and cartilage-pannus junction were stained for eosinophils, mast cells, and macrophages with monoclonal antibodies and immunolocalisation techniques.
RESULTS: Eosinophils were absent in 28 of the 31 specimens; the remaining three showed only the occasional eosinophil. By contrast the mean values for mast cell and macrophage (CD68/KP1 marker) distributions were 24 (SD 22) and 104 (SD 66) per mm2, respectively.
CONCLUSION: There are very few eosinophils in inflamed rheumatoid synovial tissue and sites of cartilage erosion despite the presence of appreciable numbers of macrophages and mast cells, the mast cells showing various states of activation. Such findings are at variance with those in allergic inflammation, in which the presence of eosinophils has been reported to be regulated by specific chemokines and adhesion molecules.

Entities:  

Mesh:

Year:  1996        PMID: 8774184      PMCID: PMC1010236          DOI: 10.1136/ard.55.8.548

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Eosinophils 1992.

Authors:  C J Spry; A B Kay; G J Gleich
Journal:  Immunol Today       Date:  1992-10

2.  Rheumatoid arthritis associated with eosinophilia.

Authors:  R S Panush; A E Franco; P H Schur
Journal:  Ann Intern Med       Date:  1971-08       Impact factor: 25.391

Review 3.  CC chemokines in allergic inflammation.

Authors:  M Baggiolini; C A Dahinden
Journal:  Immunol Today       Date:  1994-03

4.  Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion.

Authors:  M Bromley; D E Woolley
Journal:  Arthritis Rheum       Date:  1984-08

5.  Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement.

Authors:  R Hällgren; A Bjelle; P Venge
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

6.  Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder.

Authors:  J H Butterfield; K M Leiferman; G J Gleich
Journal:  Clin Exp Allergy       Date:  1993-07       Impact factor: 5.018

7.  Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.

Authors:  W B Davis; G A Fells; X H Sun; J E Gadek; A Venet; R G Crystal
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

8.  Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.

Authors:  L C Tetlow; D E Woolley
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

9.  Eosinophilic synovitis: clinical observations on a newly recognized subset of patients with dermatographism.

Authors:  J P Brown; M Rola-Pleszczynski; H A Ménard
Journal:  Arthritis Rheum       Date:  1986-09

10.  Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies.

Authors:  L C Tetlow; D E Woolley
Journal:  Ann Rheum Dis       Date:  1995-11       Impact factor: 19.103

View more
  1 in total

1.  Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?

Authors:  Joseph Paquet; Jean-Christophe Goebel; Camille Delaunay; Astrid Pinzano; Laurent Grossin; Christel Cournil-Henrionnet; Pierre Gillet; Patrick Netter; Jean-Yves Jouzeau; David Moulin
Journal:  Arthritis Res Ther       Date:  2012-03-13       Impact factor: 5.156

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.